A Study of Orforglipron (LY3502970) in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2023
This study will investigate the efficacy and safety of once daily oral orforglipron in adult participants with obesity or overweight with weight-related comorbidities.
Epistemonikos ID: 79e4a23f9a13eb40049a40fb803f4e773e6bb846
First added on: Feb 19, 2024